#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Follicle centre lymphoma follicular grade I, II – III Prostate cancer Gastrointestinal neuroendocrine tumour Marginal zone lymphoma refractory Intracranial germ cell tumour Haemolytic uraemic syndrome Intracranial calcification Hairy cell leukaemia recurrent Diabetes insipidus Pericarditis Restless legs syndrome Colorectal adenocarcinoma Pyoderma gangrenosum Adrenocortical carcinoma Glycogen storage disease type II More trials…

    Learn about Rare Diseases

    Andersen-Tawil syndrome – Treatment Lymphangiosarcoma Glomerulonephritis membranous – Diagnostics Paroxysmal nocturnal haemoglobinuria – Life with Disease Congenital nephrogenic diabetes insipidus – Diagnostics Von Willebrand’s disease Vascular malformation – Basic Information Atypical teratoid/rhabdoid tumour of CNS – Diagnostics Haemophilia – Basic Information Primary mediastinal large B-cell lymphoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    DESMOPRESSIN ACETATE Sxr1096 Cefazolin Sodium Ianalumab Pbf-999 Dasatinib Cytisine OMEGA-3-ACID ETHYL ESTERS 90 Bezafibrate Cls12311 Regn7508 Gd2Il18Cart Amitriptyline Rocuronium Bromide Remifentanil Hydrochloride Syn2 SODIUM HYDROXIDE Etrinabdione Sodium 2-Hydroxylinoleate Travoprost More therapies…

    Learn about Your Condition

    Type V hyperlipidaemia Anxiety disorder Crigler-Najjar syndrome Follicular lymphoma Hyponatraemia Arterial tortuosity syndrome Hip arthroplasty Vomiting Mechanical ventilation Neonatal respiratory failure Febrile neutropenia Colorectal cancer Adenosquamous cell lung cancer Acute hepatic failure Bronchitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Persistent corneal epithelial defect

  • Cenegermin Eye Drops for Persistent Corneal Epithelial Defect in Patients with Persistent Corneal Epithelial Defect

    Recruiting

    3 1 1
    Investigated Drugs:
    • Oxybuprocaine Hydrochloride
    • Tetracaine Hydrochloride
    • Tropicamide
    Czechia France Germany Hungary Italy The Netherlands +2
  • Study on Insulin Eye Drops for Treating Persistent Corneal Epithelial Defect in Patients with Neurotrophic or Chronic Ocular Surface Diseases

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Persistent corneal epithelial defect
    Investigated Drugs:
    • Insulin Human
    Spain
  • Study on the Safety and Effectiveness of Lufepirsen Gel for Patients with Persistent Corneal Epithelial Defects

    Recruiting

    2 1
    Investigated Diseases:
    • Persistent corneal epithelial defect
    Investigated Drugs:
    • Lufepirsen
    France Germany Italy Spain

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!